Anzeige
Mehr »
Login
Freitag, 29.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
NurExone Biologic: Technisches (täglich, wöchentlich, monatlich) & Analysten "Strong Buy"-Rating!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
268 Leser
Artikel bewerten:
(1)

Norges Bank - Form 8.3 - Willis Towers Watson PLC

Norges Bank - Form 8.3 - Willis Towers Watson PLC

PR Newswire

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.KEYINFORMATION

Name of person dealing (Note 1)Norges Bank
Company dealt inWillis Towers Watson PLC
Class of relevant security to which the dealings being disclosed relate (Note 2)Common Stock
IE00BDB6Q211
Dateofdealing19/01/2021

2.INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

LongShort
Number(%)Number(%)
(1) Relevant securities
2,628,706 (2.04%)
(2)Derivatives(otherthanoptions)
(3) Options and agreements to purchase/sell
Total
2,628,706 (2.04%)

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:LongShort
Number(%)Number(%)
(1) Relevant securities

(2)Derivatives(otherthanoptions)

(3) Options and agreements to purchase/sell
Total

Ap20

1.DEALINGS (Note 4)

(a) Purchases and sales


Purchase/sale

Number of relevant securities

Price per unit (Note 5)
Purchase
Purchase
24,195208.4808 USD

(b) Derivatives transactions (other than options transactions)

Product name,
e.g.CFD
Nature of transaction
(Note 6)
Number of relevant securities
(Note 7)
Price per unit
(Note 5)
CFDSale31,500208.5000 USD

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,
e.g.calloption
Writing,selling, purchasing, varying etc.Number of securities to which the option relates (Note 7)Exercise priceType,e.g. American, European etc.Expiry dateOption money paid/received per unit (Note 5)

(ii) Exercising

Product name,
e.g.calloption
Number of securitiesExercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Natureoftransaction
(Note 8)
DetailsPriceperunit
(if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9)YES/NO

Date of disclosure20/01/2021
ContactnamePhilippe Chiaroni
Telephonenumber+47 2407 3000
Ifa connected EFM, name of offeree/offeror with which connected
Ifa connected EFM, state nature of connection (Note 10)
Großer Dividenden-Report 2024 von Dr. Dennis Riedl
Der kostenlose Dividenden-Report zeigt ganz genau, wo Sie in diesem Jahr zuschlagen können. Das sind die Favoriten von Börsenprofi Dr. Dennis Riedl
Jetzt hier klicken
© 2021 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.